Ashland Inc (ASH) Stock Price, Quote & News

Company Profile

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Pe...

Industry: Specialty Chemicals

Sector: Basic Materials

Phone: 302 995 3000

Website: www.ashland.com

Address:

8145 Blazer Drive, Wilmington, United States

JarvisFlow Jul. 9 at 3:11 PM

UBS updates rating for Ashland ( $ASH ) to Buy, target set at 74 → 73.

0 · Reply

ZacksResearch Jul. 9 at 1:48 PM

$ASH is streamlining hard — $60M move to sharpen its edge ⚙️📉 By closing two NJ sites, ASH targets cost cuts, higher efficiency, and scaling of key tech production. Inside the full optimization plan 👉 https://www.zacks.com/stock/news/2568930/ashland-advances-strategic-60m-manufacturing-network-optimization?cid=sm-stocktwits-2-2568930-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2568930_TEASER

0 · Reply

ZacksResearch Jul. 9 at 12:29 PM

$ASH down 41.4% in a year — is it time to rethink the strategy? 📉 Ashland's $60M manufacturing optimization aims to improve efficiency and cut costs, yet the stock lags industry peers. The plan includes consolidating production and enhancing core technologies, but it's still ranked Zacks #4 (Sell). See if ASH's turnaround plan can gain traction 👉 https://www.zacks.com/stock/news/2568930/ashland-advances-strategic-60m-manufacturing-network-optimization?cid=sm-stocktwits-2-2568930-body-1013&ADID=SYND_STOCKTWITS_TWEET_2_2568930_BODY_1013

0 · Reply

NVDAMillionaire Jul. 9 at 11:47 AM

$ASH Brilliant piece that captures ASH's situation perfectly. So if you want to update your understanding of ASH or get to know ASH better, this is essential reading. https://beyondspx.com/article/ashland-s-strategic-transformation-completes-unlocking-margin-potential-ash

0 · Reply

Thestocktraderhubzee Jul. 9 at 9:30 AM

WATCHLIST JUL 09 2025 $ASH Ashland To Close Two New Jersey Plants In $60M Manufacturing Optimization Plan, Shifting Production To Larger Sites $ATR Aptar Unveils Dual-Active Material Science Technology To Protect Sensitive Pharma And Medical Devices From Moisture And Oxygen $QNRX On July 3, 2025, Quoin Pharmaceuticals And CFO Gordon Dunn Agreed To A Mutual Separation Later This Year; Mr. Dunn Will Continue In His Current Role Until His Successor Is Appointed $AGCO AGCO Corporation And TAFE Enter Fourth Amendment To Agreement; Amendment Extends Expiration Date To November 28, 2025 $TKO Esports World Cup Foundation Taps TKO-Owned IMG To Launch 'EWC Spotlight,' Merging Competitive Gaming, Entertainment And Global Broadcast Innovation

1 · Reply

john_rubias Jul. 6 at 11:50 PM

$ASH bids set on that breakout level

0 · Reply

howardlindzon Jul. 6 at 5:04 PM

5 trade ideas $AAPL $ASH $AVGO $FI $V

0 · Reply

harmongreg Jul. 6 at 2:09 PM

Dragonfly Capital - 5 Trade Ideas for Monday: Apple, Ashland, Broadcom, Fiserv and Visa $AAPL $ASH $AVGO $FI $V https://dragonflycap.com/5-trade-ideas-for-monday-apple-ashland-broadcom-fiserv-and-visa/

0 · Reply

Estimize Jun. 27 at 12:01 AM

Wall St is expecting 1.28 EPS for $ASH Q3 [Reporting 07/29 AMC] http://www.estimize.com/intro/ash?chart=historical&metric_name=eps&utm_cont

0 · Reply

Arlan1 Jun. 25 at 6:12 PM

$ASH

0 · Reply

Operations leadership changes announced at Ashland

Jul 8, 2025, 5:00 PM EDT - 7 days ago

Ashland advances strategic $60MM network optimization

May 28, 2025, 5:00 PM EDT - 6 weeks ago

Ashland hosts Innovation Day for analysts and investors

May 8, 2025, 6:45 AM EDT - 2 months ago

Valvoline Inc. Announces Kevin Willis as Chief Financial Officer

VVV

May 6, 2025, 5:15 PM EDT - 2 months ago

Ashland board authorizes quarterly dividend

May 5, 2025, 5:00 PM EDT - 2 months ago

Ashland announces executive leadership changes

May 1, 2025, 7:48 PM EDT - 2 months ago

Ashland, Inc. (ASH) Q2 2025 Earnings Call Transcript

Apr 30, 2025, 5:01 PM EDT - 2 months ago

Ashland reports second quarter fiscal 2025 results and revises full-year outlook

Apr 29, 2025, 9:00 AM EDT - 2 months ago

Ashland Place Completes Two New Financing Facilities for Sirius Aviation Capital

Apr 17, 2025, 6:30 AM EDT - 3 months ago

Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast

Apr 1, 2025, 6:59 AM EDT - 3 months ago

Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest

Mar 28, 2025, 6:59 AM EDT - 3 months ago

Ashland to host 2025 Innovation Day for analysts and investors

Mar 17, 2025, 7:00 AM EDT - 4 months ago

Ashland completes sale of Avoca business to Mane

Feb 27, 2025, 2:14 PM EST - 4 months ago

Ashland Presents Attractive Upside Emerging From The Downcycle

Feb 10, 2025, 12:53 PM EST - 5 months ago

The Best Materials Stocks to Buy

AVY BALL DD FMC GPK PKG RPM

Jan 29, 2025, 9:24 PM EST - 5 months ago

Ashland Inc. (ASH) Q1 2025 Earnings Call Transcript

Jan 28, 2025, 5:01 PM EST - 6 months ago

Ashland reports financial results for first quarter fiscal 20251, reiterates outlook for full-year fiscal 2025

Jan 23, 2025, 7:30 AM EST - 6 months ago

Forget The S&P 500 - 3 Small Dividend Stocks At Big Discounts

BNL SMG

Jan 14, 2025, 7:00 AM EST - 6 months ago

Ashland sets date for first-quarter fiscal 2025 earnings release and conference call webcast

Dec 23, 2024, 5:01 PM EST - 7 months ago

Ashland signs definitive agreement to sell Avoca business to Mane

Dec 12, 2024, 8:22 AM EST - 7 months ago

Ashland: A Stable Stock Trading At 50% Discount To Its Intrinsic Value

Dec 9, 2024, 5:01 PM EST - 7 months ago

Ashland rings opening bell at NYSE recognizes 100-year anniversary

Dec 9, 2024, 6:30 AM EST - 7 months ago

Ashland celebrates solvers, recognizes 100 years of innovation by planting trees to restore local ecosystems and support sustainable sourcing

Nov 9, 2024, 4:16 PM EST - 8 months ago

Ashland Inc. (ASH) Q4 2024 Earnings Call Transcript

Nov 8, 2024, 9:09 AM EST - 8 months ago

Top 3 Materials Stocks That Are Preparing To Pump In Q4

CE MATV

Nov 8, 2024, 7:00 AM EST - 8 months ago

Ashland to host live 2024 strategy update event for analysts and investors

Oct 28, 2024, 5:00 PM EDT - 9 months ago

Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast

Sep 19, 2024, 10:06 AM EDT - 10 months ago

D.A. Davidson Acts as Exclusive Financial Advisor to Turnspire Capital Partners for Debt Financing in Support of Turnspire's Acquisition of Pharmachem

Sep 3, 2024, 7:00 AM EDT - 11 months ago

Ashland completes sale of nutraceuticals business

Sep 3, 2024, 7:00 AM EDT - 11 months ago

Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and Solutions

Sep 3, 2024, 7:00 AM EDT - 11 months ago

Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland

Aug 7, 2024, 6:27 PM EDT - 1 year ago

Ashland Inc. (ASH) Q3 2024 Earnings Call Transcript

Aug 6, 2024, 5:01 PM EDT - 1 year ago

Ashland reports financial results1 for third quarter fiscal 2024, issues outlook for fourth quarter and full-year fiscal 2024

Jul 17, 2024, 7:00 AM EDT - 1 year ago

Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcast

Jun 18, 2024, 7:00 AM EDT - 1 year ago

Ashland achieves certification by Fair Wage Network

May 27, 2024, 10:31 PM EDT - 1 year ago

13 Upcoming Dividend Increases

ACNB CBT DE EVR FDS HBB HY

May 8, 2024, 5:01 PM EDT - 1 year ago

Ashland Board appoints Ashish K. Kulkarni as new director

May 7, 2024, 7:00 AM EDT - 1 year ago

Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business

May 7, 2024, 6:59 AM EDT - 1 year ago

Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners

May 1, 2024, 4:04 PM EDT - 1 year ago

Ashland Inc. (ASH) Q2 2024 Earnings Call Transcript

Apr 30, 2024, 5:01 PM EDT - 1 year ago

Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024

Apr 18, 2024, 6:59 AM EDT - 1 year ago

Ashland sets date for fiscal 2024 second-quarter earnings release and conference call webcast

Apr 15, 2024, 6:59 AM EDT - 1 year ago

Ashland Board appoints Scott A. Tozier as new director

Apr 3, 2024, 5:01 PM EDT - 1 year ago

Ashland announces executive organization changes to personal care and specialty additives

Jan 31, 2024, 4:34 PM EST - 1 year ago

Ashland Inc. (ASH) Q1 2024 Earnings Call Transcript

Jan 30, 2024, 5:01 PM EST - 1 year ago

Ashland reports financial results1 for first quarter fiscal 2024; issues outlook for second quarter and full-year fiscal 2024

Jan 16, 2024, 5:00 PM EST - 1 year ago

Ashland sets date for fiscal 2024 first-quarter earnings release and conference call webcast

Jan 9, 2024, 7:00 AM EST - 1 year ago

Ashland announces organization changes to finance and strategy, M&A and portfolio teams

Nov 30, 2023, 7:00 AM EST - 1 year ago

Ashland announces validation of comprehensive science-based greenhouse gas emissions reductions targets

Nov 14, 2023, 5:25 PM EST - 1 year ago

Ashland Board appoints Sanat Chattopadhyay, executive vice president, Merck & Company, as new director effective November 13, 2023

JarvisFlow Jul. 9 at 3:11 PM

UBS updates rating for Ashland ( $ASH ) to Buy, target set at 74 → 73.

0 · Reply

ZacksResearch Jul. 9 at 1:48 PM

0 · Reply

ZacksResearch Jul. 9 at 12:29 PM

0 · Reply

NVDAMillionaire Jul. 9 at 11:47 AM

0 · Reply

Thestocktraderhubzee Jul. 9 at 9:30 AM

1 · Reply

john_rubias Jul. 6 at 11:50 PM

$ASH bids set on that breakout level

0 · Reply

howardlindzon Jul. 6 at 5:04 PM

5 trade ideas $AAPL $ASH $AVGO $FI $V

0 · Reply

harmongreg Jul. 6 at 2:09 PM

0 · Reply

Estimize Jun. 27 at 12:01 AM

Wall St is expecting 1.28 EPS for $ASH Q3 [Reporting 07/29 AMC] http://www.estimize.com/intro/ash?chart=historical&metric_name=eps&utm_cont

0 · Reply

Arlan1 Jun. 25 at 6:12 PM

$ASH

0 · Reply

ZacksResearch May. 6 at 1:35 PM

$ASH misses big — but is the pain temporary or structural? Q2 earnings and revenues both missed estimates and declined year over year, as portfolio optimization actions weighed on sales. Full breakdown here 👉 https://www.zacks.com/stock/news/2463062/ashlands-q2-earnings-and-revenues-miss-estimates-down-yy?cid=sm-stocktwits-2-2463062-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2463062_TEASER

0 · Reply

Estimize Apr. 30 at 8:00 PM

Wall St is expecting 1.47 EPS for $ASH Q3 [Reporting 07/29 AMC] http://www.estimize.com/intro/ash?chart=historical&metric_name=eps&utm_cont

0 · Reply

Bsheskey Apr. 15 at 8:16 PM

$ASH Could Quickly Scale into GLP-1 API's if Pharma Tariffs take effect. $NVO or $LLY should target. ASAP

0 · Reply

JarvisFlow Apr. 9 at 5:30 PM

Wells Fargo updates rating for Ashland ( $ASH ) to Overweight, target set at 69 → 58.

0 · Reply

NVDAMillionaire Mar. 30 at 10:26 AM

$ASH Digging ASH's strategic pivot. Avoca sale looks smart. Life Sciences hit hard but Personal Care segment showing resilience. Watching how cost-cutting plays out. Cautiously optimistic on long-term potential. Might nibble on dip if market overreacts. compelling writeup: https://beyondspx.com/article/ashland-inc-ash-a-specialty-chemicals-powerhouse-navigating-challenges-with-strategic-precision

0 · Reply

IndulgeJackal Mar. 27 at 1:52 PM

$ASH 🚨 BREAKING NEWS from Mainz Biomed 🚨 Mainz Biomed just enrolled the first patient in its eAArly DETECT 2 clinical study - a groundbreaking 2,000-patient trial designed to validate its next-gen colorectal cancer (CRC) test that could shift CRC screening to prevention! 🧬🔍 Key Highlights: ✅ Industry-leading mRNA biomarkers + AI-driven algorithm ✅ Detects advanced precancerous lesions (APL) with high precision ✅ Potential to prevent CRC by catching treatable polyps early ✅ Top-line results expected Q4 2025 ✅ Pivotal U.S. study (ReconAAsense) planned for 2026 “This marks a huge milestone in our mission to eliminate colorectal cancer and save lives,” said CEO Guido Baechler. 🌍💥

0 · Reply

JarvisFlow Mar. 27 at 1:04 PM

Wells Fargo has adjusted their stance on Ashland ( $ASH ), setting the rating to Overweight with a target price of 80 → 69.

0 · Reply

JarvisFlow Mar. 26 at 12:00 PM

JP Morgan updates rating for Ashland ( $ASH ) to Overweight, target set at 68 → 71.

0 · Reply

ajmrtxl Mar. 25 at 5:09 PM

$ASH's latest data on SqueezeFinder

0 · Reply

BigSqueezeComing Mar. 24 at 11:04 AM

$DMN $ASH $IMTE $WINT $MLGO continue from AH

0 · Reply

kshonstocks Mar. 19 at 2:49 PM

chemicals act wrong, distribution in $ASH $WLK et al

0 · Reply

Market Cap	2.44B
Revenue (ttm)	2.11B
Net Income (ttm)	169.00M
EPS (ttm)	N/A
PE Ratio	13.55
Forward PE	14.43
Profit Margin	8.00%
Debt to Equity Ratio	0.54

Volume	332,908
Avg Vol	581,698
Day's Range	N/A - N/A
Shares Out	45.70M
Stochastic %K	45%
Beta	0.51
Analysts	Strong Sell
Price Target	$68.00